Gapping down
In reaction to earnings/guidance:
- KALU -7.4%, ABB -7%, CVLG -6.9%, FTI -6.3%, IBM -4.8%, GTLS -4.6%, GL -4.5%, GGG -4.1%, LRCX -3.7%, RCI -3.3%, UMPQ -3.1%, LVS -2.6%, IQV -2.6%, TCBI -2.4%, PPG -2.4%, PBR -2.4%, DFS -2.2%, HRI -2.2%, KMI -1.5% (also increases dividend), BCS -1.5%, TSLA -1.4%, BKU -1.4%, SLG -1.3%, HLX -0.9%
Other news:
- ADMA -8.1% (stock offering)
- HPK -4.5% (prices offering of 2.2 mln shares of common stock at $10.00 per share)
- RJF -4.4% (TSC to be acquired by RJF in cash and stock deal worth $1.1 bln)
- BCYP -4.3% (receives shareholder approval for combination with SAB Biotherapeutics)
- KNBE -2.7% (entered into a material definitive agreement to acquire SecurityAdvisor for an estimated total purchase consideration of ~$80 mln)
- ZLAB -1.3% (announces topline results from Phase 1b study of ZL-1102 for chronic plaque psoriasis)
- DLO -1% (prices secondary offering of 17.0 mln shares of common stock at $52.25 per share)
Analyst comments:
- LRCX -3.7% (downgraded to Hold from Buy at Summit Insights)
- LPSN -2.8% (downgraded to Underweight from Overweight at Barclays)
- FVRR -2.7% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- WIX -2% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- AVYA -1.4% (downgraded to Equal Weight from Overweight at Barclays)
- DNUT -1.1% (downgraded to Hold from Buy at HSBC Securities)